Dupilumab as an Adjunct to Oral Immunotherapy in Pediatric Patients With Peanut Allergy
R. Sharon Chinthrajah(Stanford University), Allen Radin(Regeneron (United States)), Andrea T. Hooper(Regeneron (United States)), Elizabeth Laws(Sanofi (United States)), Jamie Orengo(Regeneron (United States)), Kari C. Nadeau(Palo Alto University), Julie Wang(Shanghai Jiao Tong University), Jennifer D. Hamilton(Regeneron (United States)), Jonathan M. Spergel(University of Pennsylvania), Erik Wambre(Benaroya Research Institute), Amanda Atanasio(Regeneron (United States)), Daniel Petroni(Allergy Asthma Research Institute), Thomas B. Casale(University of South Florida), Bolanle Akinlade(Regeneron (United States)), Leda Mannent(Sanofi (France)), Mohamed Kamal(Regeneron (United States)), Wayne G. Shreffler(Massachusetts General Hospital), Stacie M. Jones(Arkansas Children's Hospital), Robert A. Wood(Johns Hopkins University), Daniel C. Adelman(University of California, San Francisco), Warner W. Carr, Anoshie Ratnayake(DecImmune Therapeutics (United States)), Jinzhong Liu(Regeneron (United States)), Jeffrey Leflein, Kiran Patel(Goethe University Frankfurt), Sayantani Sindher(Johns Hopkins University)
Cited by 33
Related Papers
Guidelines for the Diagnosis and Management of Food Allergy in the United States: Summary of the NIAID-Sponsored Expert Panel Report
|Journal of Allergy and Clinical Immunology|2010|2.3k
Eosinophilic esophagitis: Updated consensus recommendations for children and adults
|Journal of Allergy and Clinical Immunology|2011|2.1k
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
|New England Journal of Medicine|2016|2k
Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma
|New England Journal of Medicine|2019|1.7k